Skip to main content
SpringerLink
Log in

Viral vectors as a tool to model and treat Parkinson's disease

  • Current Topics in Brain Dopamine Research
  • Published:
Wiener klinische Wochenschrift Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Déglon N, Tseng JL, Bensadoun JC, Zurn AD, Arsenijevic Y, Pereira de Almeida L, Zufferey R, Trono D, Aebischer P (2000) Self-inactivating lentiviral vectors with enhanced transgene expression as potential gene transfer system in Parkinson's disease. Hum Gene Ther 11: 179–190

    Article  PubMed  Google Scholar 

  • Bensadoun JC, Déglon N, Tseng JL, Ridet JL, Zurn AD, Aebischer P (2000) Lentiviral vectors as a gene delivery system in the mouse midbrain: cellular and behavioural improvements in a 6-OHDA model of Parkinson's disease using GDNF. Exp Neurol 164: 15–24

    Article  PubMed  CAS  Google Scholar 

  • Kordower JH, Bloch J, Ma S, Chu Y, Palfi S, Roitberg B, Emborg M, Hantraye P, Déglon N, Aebischer P (1999) Lentiviral gene transfer to the nonhuman primate brain. Exp Neurol 160: 1–16

    Article  PubMed  CAS  Google Scholar 

  • Kordower JH, Emborg ME, Bloch J, Ma SY, Chu YP, Leventhal L, McBride J, Chen EY, Palfi S, Roitberg BZ, et al (2000) Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease. Science 290: 767–773

    Article  PubMed  CAS  Google Scholar 

  • Ridet JL, Bensadoun JC, Deglon N, Aebischer P, Zurn AD (2006) Lentivirus-mediated expression of glutathione peroxidase: neuroprotection in murine models of Parkinson's disease. Neurobiol Dis 21: 29–34

    Article  PubMed  CAS  Google Scholar 

  • Lo Bianco C, Ridet JL, Schneider BL, Deglon N, Aebischer P (2002) alpha-Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease. Proc Natl Acad Sci USA 99: 10813–10818

    Article  PubMed  CAS  Google Scholar 

  • Lo Bianco C, Deglon N, Pralong W, Aebischer P (2004a) Lentiviral nigral delivery of GDNF does not prevent neurodegeneration in a genetic rat model of Parkinson's disease. Neurobiol Dis 17: 283–289

    Article  CAS  Google Scholar 

  • Lo Bianco C, Schneider BL, Bauer M, Sajadi A, Brice A, Iwatsubo T, Aebischer P (2004b) Lentiviral vector delivery of parkin prevents dopaminergic degeneration in an alpha-synuclein rat model of Parkinson's disease. Proc Natl Acad Sci USA 101: 17510–17515

    Article  CAS  Google Scholar 

Download references

Authors
  1. Jean-Charles Bensadoun
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Patrick Aebischer
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bensadoun, JC., Aebischer, P. Viral vectors as a tool to model and treat Parkinson's disease. Wien Klin Wochenschr 118, 568–570 (2006). https://doi.org/10.1007/s00508-006-0736-5

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00508-006-0736-5

Keywords

Search

Navigation